within Pharmacolibrary.Drugs.P_AntiparasiticProductsInsecticidesAndRepellents.P01A_AgentsAgainstAmoebiasisAndOtherProtozoalDiseases.P01AC02_Clefamide;
model Clefamide 
   extends Pharmacolibrary.Drugs.ATC.P.P01AC02;

  annotation(Documentation(
    info ="<html><body><p>Clefamide is an antiprotozoal agent formerly used for the treatment of intestinal amoebiasis and other protozoal infections. It is a dichlorophenyl derivative with a long history of use. Clefamide is not approved or widely used in current medical practice due to the availability of more effective and safer alternatives.</p><h4>Pharmacokinetics</h4><p>No published human pharmacokinetic data for clefamide are available in the literature. All reported pharmacokinetic parameters are estimated based on chemical class analogies and standard values for orally administered antiprotozoals.</p><h4>References</h4><ol></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>",
    experiment(StartTime = 0, StopTime = 86400, Tolerance = 1e-09, Interval = 1)
  ));  
end Clefamide;
